Subarachnoid haemorrhage (SAH): brain damage, cognitive and behavioral functioning as predictors of recovery.
- Conditions
- intracranial haemorrhagesubarachnoid haemorrhage10002363
- Registration Number
- NL-OMON54915
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 235
1. A SAH patient, the diagnosis being based on clinical features in combination
with CT angiography (CTA) or digital subtraction angiography (DSA).
2. The patient must be able to understand the instructions of the
neuropsychological assessment and be mentally and physically able to undergo
the research activities; this will be assessed in a consultation between the
treating doctor (neurosurgeon) and researcher (neuropsychologist).
3. Sufficient knowledge of the Dutch language.
4. Age 18 or older
A limited physical and/or cognitive condition which makes it impossible for
patients to undergo the neuropsychological assessment and MRI.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure consists of the score on the Impact on<br /><br>Participation and Autonomy (IPA) (Cardol, 2005) questionnaire 1 year after SAH.</p><br>
- Secondary Outcome Measures
Name Time Method <p>- The score on the IPA 2 years after SAH;<br /><br>- The score on the mRS 1 and 2 years after SAH;<br /><br>- Performance on neuropsychological tests (intelligence, memory, attention,<br /><br>mental speed, language, visuoconstruction skills, executive functions and<br /><br>social cognition);<br /><br>- Scores on questionnaires (complaints, fatigue, anxiety/depression, stress,<br /><br>coping, personality, behavior, quality of life)<br /><br>- Neuro-imaging outcomes (RS-fMRI, DWI, VBM)<br /><br>o ASL/VAI: cerebral blood flow (CBF), cerebral blood volume (CBV), vessel size,<br /><br>oxygen saturation, vessel architecture<br /><br>o DTI: fractional anisotropy (FA) en apparent diffusion coefficient (ADC)<br /><br>o SWI/QSM: affected tissue volume en hemosiderosis volume<br /><br>o Synthetic MRI: quantitative T1, T2, proton density (PD) values.</p><br>